发明名称 MODIFIED ANTIBODY WITH ENHANCED BIOLOGICAL ACTIVITY
摘要 <P>PROBLEM TO BE SOLVED: To provide methods for enhancing effector activities of antibodies. <P>SOLUTION: Modified antibodies in which Fc domains are linked in tandem to the C terminus of the heavy chain, and modified antibodies in which Fc domains are linked in tandem via spacers are produced; and the affinity for Fc receptors, CDC activity, and ADCC activity are measured. It has been reported that the CDC activity is not enhanced even if multiple Fcs are linked. However the modified antibodies exhibit the enhanced ADCC activity. The methods enable provision of antibody pharmaceuticals having a marked therapeutic effect. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012136519(A) 申请公布日期 2012.07.19
申请号 JP20120004674 申请日期 2012.01.13
申请人 TOKYO UNIV OF SCIENCE;CHEMO-SERO-THERAPEUTIC RESEARCH INST;TEIJIN PHARMA LTD 发明人 MASUYASU YASUHIKO;NAGASHIMA HIROAKI
分类号 C07K16/18;A61K39/395;C07K16/28;C12N15/09;C12P21/02 主分类号 C07K16/18
代理机构 代理人
主权项
地址